4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
8.71
+0.11 (1.28%)
At close: May 26, 2026, 4:00 PM EDT
8.71
0.00 (-0.01%)
After-hours: May 26, 2026, 7:34 PM EDT
4D Molecular Therapeutics Market Cap
4D Molecular Therapeutics has a market cap or net worth of $455.33 million as of May 26, 2026. Its market cap has increased by 203.37% in one year.
Market Cap
455.33M
Enterprise Value
18.23M
1-Year Change
203.37%
Ranking
Category
Stock Price
$8.71
Market Cap Chart
Since the IPO on December 11, 2020, 4D Molecular Therapeutics's market cap has decreased from $580.38M to $455.33M, a decrease of -21.55%. That is a compound annual growth rate of -4.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 449.58M | 4.92% |
| Dec 31, 2025 | 428.51M | 66.42% |
| Dec 31, 2024 | 257.49M | -70.27% |
| Dec 29, 2023 | 866.19M | 20.40% |
| Dec 30, 2022 | 719.43M | 2.03% |
| Dec 31, 2021 | 705.13M | -35.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 467.75M |
| Upstream Bio | 455.50M |
| Ocugen | 453.62M |
| Autolus Therapeutics | 452.44M |
| Neurogene | 437.87M |
| Sagimet Biosciences | 437.82M |
| Fulcrum Therapeutics | 437.78M |
| ADC Therapeutics | 431.18M |